Agios Pharmaceuticals IncNASDAQ:AGIO
- LAST PRICE40.5600
- TODAY'S CHANGE (%)-1.2300 (-2.9433%)
- Bid / Lots23.0000/ 1
- Ask / Lots47.5000/ 1
- Open / Previous Close41.4300 / 41.7900
- Day Range
- 52 Week Range
- Volume498,577
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AGIO |
|---|---|---|
| 09:32 ET | 3065 | 41.43 |
| 09:34 ET | 300 | 41.595 |
| 09:36 ET | 990 | 41.955 |
| 09:38 ET | 100 | 42.21 |
| 09:41 ET | 200 | 42.17 |
| 09:43 ET | 760 | 41.47 |
| 09:45 ET | 100 | 41.57 |
| 09:48 ET | 200 | 41.57 |
| 09:50 ET | 141 | 41.21 |
| 09:52 ET | 200 | 41.1 |
| 09:56 ET | 1500 | 41.45 |
| 09:57 ET | 200 | 41.445 |
| 09:59 ET | 300 | 41.46 |
| 10:01 ET | 457 | 41.54 |
| 10:03 ET | 200 | 41.54 |
| 10:06 ET | 200 | 41.55 |
| 10:08 ET | 300 | 41.595 |
| 10:10 ET | 100 | 41.65 |
| 10:12 ET | 300 | 41.745 |
| 10:15 ET | 700 | 41.4 |
| 10:17 ET | 215 | 41.4995 |
| 10:19 ET | 500 | 41.36 |
| 10:21 ET | 100 | 41.415 |
| 10:24 ET | 676 | 41.24 |
| 10:26 ET | 900 | 41.2 |
| 10:28 ET | 100 | 41.19 |
| 10:32 ET | 606 | 41.265 |
| 10:33 ET | 300 | 41.25 |
| 10:35 ET | 100 | 41.25 |
| 10:37 ET | 400 | 41.25 |
| 10:42 ET | 411 | 40.91 |
| 10:44 ET | 200 | 40.85 |
| 10:46 ET | 150 | 40.88 |
| 10:48 ET | 500 | 40.81 |
| 10:57 ET | 1848 | 41.005 |
| 11:00 ET | 694 | 40.98 |
| 11:02 ET | 1200 | 40.985 |
| 11:04 ET | 100 | 40.98 |
| 11:06 ET | 100 | 41.15 |
| 11:08 ET | 800 | 41.165 |
| 11:09 ET | 1500 | 41.09 |
| 11:11 ET | 1100 | 41.15 |
| 11:13 ET | 100 | 41.2 |
| 11:15 ET | 1300 | 41.14 |
| 11:18 ET | 400 | 41.14 |
| 11:26 ET | 500 | 41.16 |
| 11:29 ET | 2638 | 41.11 |
| 11:31 ET | 400 | 41.215 |
| 11:33 ET | 700 | 41.32 |
| 11:36 ET | 3408 | 41.15 |
| 11:38 ET | 100 | 41.225 |
| 11:40 ET | 300 | 41.17 |
| 11:44 ET | 800 | 41.29 |
| 11:47 ET | 455 | 41.3 |
| 11:49 ET | 800 | 41.29 |
| 11:51 ET | 200 | 41.345 |
| 11:56 ET | 800 | 41.32 |
| 11:58 ET | 100 | 41.355 |
| 12:03 ET | 300 | 41.28 |
| 12:05 ET | 2144 | 41.25 |
| 12:14 ET | 400 | 41.17 |
| 12:16 ET | 100 | 41.17 |
| 12:18 ET | 100 | 41.17 |
| 12:20 ET | 200 | 41.17 |
| 12:21 ET | 100 | 41.2 |
| 12:23 ET | 500 | 41.2 |
| 12:25 ET | 100 | 41.2 |
| 12:30 ET | 1397 | 41.2 |
| 12:34 ET | 813 | 41.15 |
| 12:36 ET | 400 | 41.15 |
| 12:38 ET | 904 | 41.02 |
| 12:39 ET | 1231 | 41.05 |
| 12:45 ET | 418 | 41.03 |
| 12:48 ET | 1300 | 40.94 |
| 12:50 ET | 895 | 40.95 |
| 12:52 ET | 300 | 40.91 |
| 12:54 ET | 400 | 40.83 |
| 12:56 ET | 400 | 40.8 |
| 12:57 ET | 300 | 40.89 |
| 12:59 ET | 1400 | 40.805 |
| 01:01 ET | 400 | 40.92 |
| 01:06 ET | 200 | 40.82 |
| 01:08 ET | 100 | 40.82 |
| 01:10 ET | 400 | 40.8 |
| 01:12 ET | 788 | 40.73 |
| 01:17 ET | 300 | 40.64 |
| 01:19 ET | 107 | 40.64 |
| 01:21 ET | 500 | 40.685 |
| 01:24 ET | 920 | 40.77 |
| 01:26 ET | 700 | 40.77 |
| 01:28 ET | 100 | 40.795 |
| 01:30 ET | 700 | 40.705 |
| 01:32 ET | 900 | 40.65 |
| 01:33 ET | 500 | 40.76 |
| 01:35 ET | 374 | 40.775 |
| 01:37 ET | 300 | 40.73 |
| 01:39 ET | 1059 | 40.715 |
| 01:42 ET | 800 | 40.58 |
| 01:44 ET | 900 | 40.63 |
| 01:48 ET | 200 | 40.55 |
| 01:50 ET | 2098 | 40.51 |
| 01:51 ET | 3100 | 40.56 |
| 01:53 ET | 1817 | 40.535 |
| 01:55 ET | 3664 | 40.51 |
| 01:57 ET | 701 | 40.5 |
| 02:00 ET | 877 | 40.49 |
| 02:02 ET | 400 | 40.505 |
| 02:04 ET | 756 | 40.44 |
| 02:06 ET | 300 | 40.45 |
| 02:08 ET | 600 | 40.49 |
| 02:09 ET | 1580 | 40.53 |
| 02:11 ET | 263 | 40.52 |
| 02:13 ET | 4269 | 40.495 |
| 02:15 ET | 500 | 40.51 |
| 02:18 ET | 1200 | 40.49 |
| 02:20 ET | 600 | 40.47 |
| 02:22 ET | 400 | 40.46 |
| 02:24 ET | 200 | 40.46 |
| 02:26 ET | 607 | 40.46 |
| 02:27 ET | 900 | 40.46 |
| 02:29 ET | 220 | 40.46 |
| 02:31 ET | 11723 | 40.665 |
| 02:33 ET | 12895 | 40.795 |
| 02:36 ET | 500 | 40.71 |
| 02:38 ET | 500 | 40.62 |
| 02:40 ET | 600 | 40.65 |
| 02:42 ET | 1200 | 40.735 |
| 02:44 ET | 975 | 40.6901 |
| 02:45 ET | 100 | 40.76 |
| 02:47 ET | 1200 | 40.54 |
| 02:49 ET | 100 | 40.54 |
| 02:51 ET | 400 | 40.54 |
| 02:54 ET | 200 | 40.55 |
| 02:56 ET | 200 | 40.59 |
| 02:58 ET | 400 | 40.53 |
| 03:00 ET | 500 | 40.52 |
| 03:02 ET | 800 | 40.49 |
| 03:03 ET | 400 | 40.48 |
| 03:05 ET | 1400 | 40.52 |
| 03:07 ET | 800 | 40.63 |
| 03:09 ET | 100 | 40.62 |
| 03:14 ET | 1693 | 40.54 |
| 03:18 ET | 100 | 40.61 |
| 03:20 ET | 900 | 40.6 |
| 03:21 ET | 987 | 40.55 |
| 03:23 ET | 586 | 40.52 |
| 03:25 ET | 434 | 40.48 |
| 03:27 ET | 2000 | 40.52 |
| 03:30 ET | 3535 | 40.45 |
| 03:32 ET | 4091 | 40.59 |
| 03:34 ET | 2477 | 40.86 |
| 03:36 ET | 1595 | 40.8 |
| 03:38 ET | 1780 | 40.63 |
| 03:39 ET | 4250 | 40.665 |
| 03:41 ET | 1899 | 40.65 |
| 03:43 ET | 4227 | 40.505 |
| 03:45 ET | 3698 | 40.59 |
| 03:48 ET | 5243 | 40.55 |
| 03:50 ET | 1775 | 40.54 |
| 03:52 ET | 4662 | 40.455 |
| 03:54 ET | 5513 | 40.42 |
| 03:56 ET | 11459 | 40.38 |
| 03:57 ET | 28734 | 40.52 |
| 03:59 ET | 124073 | 40.56 |
Sep 27, 2024
DJ Agios Pharmaceuticals Down Over 6%, on Pace for Largest Percent Decrease Since September 2022 -- Data Talk, from 1:36PM ET on Friday Sep 27, 2024 by Dow Jones
1:36PM ET on Friday Sep 27, 2024 by Dow JonesDJ Agios Pharmaceuticals Cut to Market Perform From Outperform by Leerink Partners, from 7:40AM ET on Friday Sep 27, 2024 by Dow Jones
7:40AM ET on Friday Sep 27, 2024 by Dow Jones
Sep 19, 2024
DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 9:18AM ET on Thursday Sep 19, 2024 by Dow Jones
9:18AM ET on Thursday Sep 19, 2024 by Dow Jones
Sep 11, 2024
DJ Agios Gets FDA Orphan Designation for Tebapivat in Myelodysplastic Syndromes, from 7:28AM ET on Wednesday Sep 11, 2024 by Dow Jones
7:28AM ET on Wednesday Sep 11, 2024 by Dow JonesAgios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS), from 7:00AM ET on Wednesday Sep 11, 2024 by Dow Jones
7:00AM ET on Wednesday Sep 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agios Pharmaceuticals Inc | 2.4B | -6.2x | --- |
SpringWorks Therapeutics Inc | 2.4B | -7.2x | --- |
Verona Pharma PLC | 2.3B | -19.8x | --- |
Janux Therapeutics Inc | 2.3B | -48.3x | --- |
CG Oncology Inc | 2.4B | -30.8x | --- |
Keros Therapeutics Inc | 2.3B | -11.7x | --- |
Company Information
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Contact Information
- Headquarters
- 88 Sidney StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-649-8600
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Jacqualyn Fouse
- Chief Executive Officer, Director
- Brian Goff
- Chief Financial Officer
- Cecilia Jones
- Chief Legal Officer
- James Burns
- Chief Medical Officer, Head - Research and Development
- Sarah Gheuens
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $31.3M |
Shares Outstanding | 56.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.76 |
EPS | $-6.49 |
Book Value | $14.50 |
P/E Ratio | -6.2x |
Price/Sales (TTM) | 75.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,293.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
